Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Waldenstrom Macroglobulinemia × Topotecan × Clear all

Sponsor

Conditions

Ovarian Neoplasms 22 Small Cell Lung Carcinoma 20 Neuroblastoma 12 Fallopian Tube Neoplasms 10 Uterine Cervical Neoplasms 8 Carcinoma, Ovarian Epithelial 7 Lung Neoplasms 5 Neoplasm Metastasis 4 Carcinoma, Non-Small-Cell Lung 4 Leukemia, Myeloid, Acute 3 Ganglioneuroblastoma 3 Brain Neoplasms 3 Sarcoma 2 Recurrence 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neoplasms 2 Gliosarcoma 2 Glioblastoma 2 Thrombocythemia, Essential 1 Sarcoma, Ewing 1 Retinoblastoma 1 Retinal Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Peritoneal Neoplasms 1 Osteosarcoma 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Myeloma 1 Medulloblastoma 1

Interventions

Rituximab 44 fludarabine phosphate 24 Cyclophosphamide 22 Whole-Body Irradiation 21 Peripheral Blood Stem Cell Transplantation 19 Mycophenolic Acid 18 Cyclosporine 14 Tacrolimus 13 Dexamethasone 13 ibrutinib 11 Bortezomib 11 Calcium Dobesilate 10 Busulfan 10 Antilymphocyte Serum 9 Sirolimus 8 Etoposide 8 Methotrexate 7 Lenalidomide 7 Cyclosporins 7 Melphalan 6 Everolimus 6 idelalisib 5 Filgrastim 5 thymoglobulin 4 carfilzomib 4 Indium 4 In Situ Hybridization, Fluorescence 4 Granulocyte Colony-Stimulating Factor 4 Flow Cytometry 4 pembrolizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡